fbpx

GBM Awareness Day is July 17. Join us in raising awareness all month long! Learn more.

MindMatters White Logo

Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.

Subscribe to MindMatters

2023 ABTA National Conference Returns To Chicago

Learn, engage, and connect at the 2023 ABTA National Conference.
Learn, engage, and connect at the 2023 ABTA National Conference.

Get inspired and learn the latest advances in brain tumor treatment at the ABTA National Conference, returning September 8-9 to the Loews Chicago O’Hare Hotel and online. Registration is free and now open!

The annual conference brings together more than a thousand patients, caregivers and survivors to explore treatment innovations, engage with leading experts, and connect with each other.

This year, you can choose your conference experience. Whether you attend in person or join virtually, we can’t wait to see you!

Tailored Education & Networking

The two-day conference features educational sessions across all major brain tumor types, presented by the nation’s top brain tumor specialists.  

Program highlights include:

  • Treatment panel covering how different treatments work together and new tech advancements. 
  • Looking behind the scenes of a brain tumor board and how experts craft treatment plans. 
  • Breakout sessions addressing mental wellbeing and patient empowerment. 
  • Patients sharing their first-hand experience.

The conference also features opportunities to network with other attendees, speakers and researchers.

Planning Your Experience

The hybrid format lets you choose the experience that best suits your needs. Explore your options:

Attending In Person

Attending Virtually

If you have questions or need help with registration, please contact ABTA Patient Services at info@abta.org, or call our CareLine at 800-886-2282 during weekday business hours. 

Picture of Jessie Schlacks

Jessie Schlacks

Jessie is Managing Editor of the bi-monthly e-newsletter MindMatters. Submit story ideas or questions to jschlacks@abta.org.


 

Make a Difference TOday

Your generosity fuels progress. The American Brain Tumor Association has already invested over $35 million in life-changing brain tumor research, leading to breakthroughs like the FDA approval of vorasidenib, a groundbreaking treatment for low-grade glioma.

Through our Meet Hope Head On campaign, we’re not just funding critical research—we’re also providing free resources and support to patients and caregivers navigating the challenges of a brain tumor diagnosis.

Share This Content:

Share:

More Posts

Upcoming Events

Educational Resources

Always free for patients & caregivers

Gina & Tim Abbas
Caregiver & Anaplastic Astrocytoma Survivor

giving tuesday logo

TRIPLE Your Impact!

Donate now and your gift will be tripled thanks to our long-time supporters the Will Hicks Charitable Association and the KM Legacy Foundation.